Skip to main content

Table 7 Predictors of HRQoL of DAAs therapy users prior, during and at the end of therapy

From: Health-related quality of Life in patients with chronic hepatitis C receiving Sofosbuvir-based treatment, with and without Interferon: a prospective observational study in Egypt

Model

Summary of the model

Unstandardized Coefficients

Standardized Coefficients

  

95.0% Confidence Interval for B

Collinearity Statistics

R

R2

AdjR2

B

Beta

t

Sig.

Lower Bound

Upper Bound

Tolerance

VIF

T0

(Constant)

.63

.39

.38

15.79

 

4.46

.000

8.69

22.89

  

Depression-T0

1.11

.41

3.13

.003

.39

1.83

.65

1.53

Anxiety-T0

.98

.29

2.21

.032

.09

1.87

.65

1.53

T1

(Constant)

.88

.78

.76

18.13

 

1.45

.153

-6.95

43.21

  

Stress-T1

1.39

.44

4.04

.000

.70

2.09

.36

2.76

HRQoL-T0

.37

.31

3.54

.001

.16

.58

.56

1.77

Anxiety-T1

.91

.24

2.27

.028

.10

1.72

.37

2.66

BMI-T1

-2.39

-.47

-2.82

.007

-4.11

-.69

.16

6.25

BMI-T0

1.91

.35

2.12

.040

.09

3.730

.15

6.32

T2

(Constant)

.91

.83

.81

34.92

 

3.42

.002

13.97

55.87

  

HRQoL-T1

.68

.72

5.52

.000

.43

.93

.36

2.72

Anxiety-T2

2.11

.66

5.27

.000

1.29

2.93

.46

2.17

MSPSS-T2

-12.81

-.25

-3.09

.005

-21.33

-4.29

.93

1.06

Anxiety-T1

-1.14

-.33

-2.11

.044

-2.25

-.03

.25

3.91

  1. HRQoL-T0 health-related quality of life time 0, BMI-T1 body mass index time 1, BMI-T0 body mass index time 0, HRQoL-T1 health-related quality of life time 1, MSPSS-T2 Multidimensional Scale of Perceived Social Support time 2
  2. P value significant at two tailed